Company profile: Enara Bio
1.1 - Company Overview
Company description
- Provider of cancer immunotherapy solutions targeting the T-cell/cancer cell interface, offering the EDAPT platform to discover cancer-specific Dark Antigens, TCR-directed immunotherapies, and off-the-shelf therapeutic cancer vaccines targeting multiple Dark Antigens for broad patient populations.
Products and services
- Dark Antigens: Population-shared targets derived from genomic dark matter, uniquely presented on cancer cells to support precise immunotherapy targeting across diverse patient cohorts
- EDAPT Platform: Computationally-integrated platform combining bioinformatics, immunopeptidomics, target validation, and immunology to discover cancer-specific Dark Antigens for developing targeted immunotherapies
- Therapeutic Cancer Vaccines: Off-the-shelf vaccines co-developed with Boehringer Ingelheim, targeting multiple Dark Antigens to deliver targeted cancer immunotherapies designed to treat broad patient populations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Enara Bio
IDEC Pharmaceuticals
HQ: United States
Website
- Description: Provider of therapy development targeting neurodegenerative, hematologic, and autoimmune diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDEC Pharmaceuticals company profile →
Intact Medical
HQ: United States
Website
- Description: Provider of minimally invasive systems for volumetric excision of tissue for diagnostic and therapeutic applications in select cancer markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intact Medical company profile →
Noviga Research
HQ: Sweden
Website
- Description: Provider of research and development of small molecules aimed at new, more effective cancer treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noviga Research company profile →
BioVie
HQ: United States
Website
- Description: Provider of biotechnological research and development focused on innovative therapies for the treatment of liver disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioVie company profile →
GigaGen
HQ: United States
Website
- Description: Provider of recombinant biotherapeutic discovery and development, advancing a pipeline of first-in-class biotherapeutics, including novel oncology antibody drug combinations and the world's first recombinant polyclonal hyperimmune gammaglobulin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GigaGen company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Enara Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Enara Bio
2.2 - Growth funds investing in similar companies to Enara Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Enara Bio
4.2 - Public trading comparable groups for Enara Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →